CULLINAN THERAPEUTICS INC
CGEM·230031106·US·Common Stock·Healthcare - Biotechnology-13D/G
CGEM (CULLINAN THERAPEUTICS INC) is held by 97 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($63.2M), STATE STREET CORP ($36.2M), VANGUARD CAPITAL MANAGEMENT LLC ($35.3M). Net institutional sentiment: Mixed.
97
Holders
Avg rating(20 Elite)
$394.2M
Total Value
64% (103)
Fund Consensus
61 buying - 34 selling
Who's Trading
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
InsiderMJMichaelson JenniferExercise 4K shMay 5, 2026
InsiderMJMichaelson JenniferSell $114KMay 5, 2026
InsiderMJMichaelson JenniferSell $3KMay 5, 2026
InsiderMJMichaelson JenniferSell $125KMar 5, 2026
ActivistKYKynam Capital Management, LP5.3%Mar 4, 2026
InsiderMJMichaelson JenniferSell $25KFeb 25, 2026
InsiderANAHMED NADIMSell $196KFeb 24, 2026
InsiderMJMichaelson JenniferSell $52KFeb 24, 2026
13F: Insider & Congress:
Showing 1-20 of 103
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer